Shallcross Steven A
SEC-identified person · CIK 1263501 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Theriva Biologics, Inc. TOVX | Director · Interim CEO and CFO | filed 2015 - 2026 |
| Newgioco Group, Inc. NWGI | Director | filed 2019 - 2023 |
| Twin Vee Powercats, Co. [VEEE] | Director | filed 2021 - 2021 |
| Nuo Therapeutics, Inc. gtf | SEE REMARKS | filed 2013 - 2014 |
| Vanda Pharmaceuticals Inc. VNDA | Sr. VP, CFO, Treasurer | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.